Anna Skowron
About Anna Skowron
Anna Skowron (age 38) was appointed Interim Chief Financial Officer of Entero Therapeutics on March 7, 2025. She is a licensed CPA (Ontario) and principal of Skowron Accounting Professional Corporation since 2015, with 14+ years of experience spanning financial reporting, compliance, corporate governance, business strategy, consolidated reporting across North America for a global steel corporation, and Global Financial Controller experience at a multi-national technology provider. She holds a Bachelor of Commerce and Finance (Accounting and Economics) from the University of Toronto and became a member of the Institute of Chartered Accountants of Ontario in 2014 . Her appointment is under a CFO consulting agreement paying $8,333 per month effective March 7, 2025, renewable month-to-month with 10 business days’ termination notice, and standard indemnification; no equity awards were disclosed at appointment .
Company performance context (pre-tenure):
| Metric | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|
| Value of Initial $100 Investment (TSR) | $(48.49) | $(28.20) | $(0.10) |
| Net Loss ($) | $(14,629,642) | $(15,794,983) | $(18,059,336) |
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Skowron Accounting Professional Corporation | Principal | 2015–present | Provided CFO-level services, financial reporting, compliance, governance, and business strategy; key role in acquisitions and capital raising across industries |
| Global steel corporation (North America) | Consolidated Reporting Manager | — | Managed consolidated reporting across North America |
| Multi-national North American-domiciled technology provider | Global Financial Controller | — | Led global financial control for technology operations |
External Roles
No public company directorships or committee roles were disclosed in the 2025 DEF 14A and March 2025 8-K appointing Skowron .
Fixed Compensation
| Component | Amount | Effective Date | Terms |
|---|---|---|---|
| CFO consulting fee (monthly) | $8,333.33 | March 7, 2025 | Month-to-month renewal; either party may terminate with 10 business days’ notice; pro-rata payment upon termination |
| Expense reimbursement | As incurred, per policy | Ongoing | Reasonable business expenses reimbursed within policy timelines with substantiation |
| Indemnification & D&O | Policy maintained | Ongoing | Full indemnification to fullest extent permitted under DGCL; D&O liability coverage maintained |
Notes:
- The agreement is an independent contractor arrangement; no employee benefits (vacation, retirement, health, etc.) and tax obligations borne by consultant .
- Choice of law: New York; arbitration under AAA; submission to New York courts; survives termination in specified respects .
Performance Compensation
No target bonus %, actual bonus, RSUs/PSUs, options, or performance metric weightings were disclosed for Skowron at or since appointment. The CFO consulting agreement specifies cash-only monthly compensation without variable pay components or equity grants .
Equity Ownership & Alignment
| Category | Detail |
|---|---|
| Beneficial ownership (as of May 15, 2025) | “—” shares; percent “—” (company-wide base 4,765,729 shares outstanding) |
| Vested vs. unvested shares | Not disclosed for Skowron |
| Options (exercisable/unexercisable) | Not disclosed for Skowron |
| Shares pledged as collateral | No pledging disclosure for Skowron; company policy prohibits short selling and hedging; all insider transactions must be pre-cleared by the CFO |
| Ownership guidelines | No executive stock ownership multiple-of-salary guideline disclosed; insider trading policy mandates pre-clearance and blackout compliance; Rule 10b5-1 plan guidelines included |
Policy alignment signals:
- Hedging and short selling are prohibited for all insiders; transactions require pre-clearance by the CFO, and blackout periods apply .
- Indemnification agreement includes exceptions for compensation recovery and Section 16(b), indicating exposure to clawback/recovery under applicable laws even if formal company clawback policy is not described in the proxy .
Employment Terms
| Term | Detail |
|---|---|
| Engagement structure | Non-employee CFO via Skowron Accounting Professional Corporation |
| Start date | Effective March 7, 2025 |
| Compensation | $8,333.33 per month; subject to periodic review |
| Term & renewal | Month-to-month; terminable by company or consultant with 10 business days’ notice |
| Confidentiality & IP | Strict confidentiality; company property retained by company; survives termination |
| Conflicts | Prohibits engaging in activities causing a conflict of interest; company may terminate upon material conflict |
| Indemnification & D&O | Full indemnification to fullest extent under DGCL; D&O insurance maintained, coverage customary |
| Dispute resolution | New York law; AAA arbitration; New York jurisdiction |
Governance & Shareholder Feedback (context)
| Item | 2025 Vote Outcome |
|---|---|
| Say-on-Pay (advisory) | For 415,176; Against 77,434; Abstain 15,048; Broker non-votes 1,328,218 |
| Board election | Five directors elected for one-year term |
| Reverse split authorization | Approved (ratio 1:2 to 1:20) |
Investment Implications
- Alignment: Cash-only, month-to-month consulting arrangement with no disclosed equity grants or ownership suggests limited direct equity alignment. Beneficial ownership shows no shares for Skowron as of May 15, 2025, reducing near-term insider selling pressure but also limiting alignment with TSR goals .
- Retention risk: The CFO agreement’s at-will, month-to-month structure with 10 business days’ termination notice elevates transition risk versus typical multi-year executive employment agreements with severance/change-of-control protections .
- Control & compliance: CFO-centric pre-clearance and blackout enforcement strengthens trading controls; hedging/short selling prohibitions are a positive governance signal, though pre-clearance by the CFO requires robust oversight to mitigate self-clear risks .
- Pay-for-performance: No disclosed variable pay or performance metrics tied to Skowron’s compensation; if continued, this structure may emphasize near-term cash discipline over incentive-driven strategic outcomes relative to TSR and profitability targets .
- Monitoring signals: Watch for future Form 4 filings indicating any equity acquisitions by Skowron, adoption of Rule 10b5-1 plans, or subsequent equity grants via proxy/8-K as potential shifts in alignment. Also monitor any updates to clawback policy disclosures and insider trading policy administration in future proxies/8-Ks .